// Auto-generated - do not edit
export const substanceName = "AB-CHMINACA";
export const sources = [{"id":"protestkit","fileName":"PROTESTKIT - AB-CHMINACA.json","displayName":"Protest Kit","size":3812},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - AB-CHMINACA.md","displayName":"TripSit Factsheets","size":512},{"id":"wikipedia","fileName":"WIKIPEDIA - AB-CHMINACA.md","displayName":"Wikipedia","size":1061}];
export const contents: Record<string, string> = {
  "protestkit": `{
  "url": "https://drugs.tripsit.me/ab-chminaca",
  "experiencesUrl": "https://www.reddit.com/search/?q=AB-CHMINACA",
  "name": "AB-CHMINACA",
  "aliases": [],
  "aliasesStr": "",
  "summary": "A synthetic cannabinoid related to AB-FUBINACA which has had some mild popularity. There have been reports of death in overdose, similar to AB-FUBINACA and it has a low threshold dose. Exercise caution.",
  "reagents": null,
  "classes": {
    "chemical": [
      "Cannabinoid"
    ]
  },
  "toxicity": null,
  "addictionPotential": null,
  "tolerance": null,
  "crossTolerances": null,
  "roas": [
    {
      "name": "Oral",
      "dosage": [
        {
          "name": "Light",
          "value": "50-100ug"
        },
        {
          "name": "Common",
          "value": "100-250ug"
        },
        {
          "name": "Strong",
          "value": "250-400ug"
        },
        {
          "name": "Heavy",
          "value": "400ug+"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "0.33 - 1.33 hours"
        },
        {
          "name": "Duration",
          "value": "5.0 - 12.0 hours"
        },
        {
          "name": "After effects",
          "value": "5.0 - 12.0 hours"
        }
      ]
    },
    {
      "name": "Vapourized",
      "duration": [
        {
          "name": "Onset",
          "value": "0.02 - 0.08 hours"
        },
        {
          "name": "Duration",
          "value": "1.0 - 2.0 hours"
        },
        {
          "name": "After effects",
          "value": "2.0 - 4.0 hours"
        }
      ]
    }
  ],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Caution"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Caution"
    },
    {
      "name": "Alcohol",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Amphetamines",
      "status": "Caution"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Cocaine",
      "status": "Caution"
    },
    {
      "name": "DMT",
      "status": "Caution"
    },
    {
      "name": "DOx",
      "status": "Caution"
    },
    {
      "name": "DXM",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "GHB/GBL",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Gabapentinoids",
      "status": "Unsafe"
    },
    {
      "name": "Ketamine",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "LSD",
      "status": "Caution"
    },
    {
      "name": "MAOIs",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MDMA",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MMC class",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MXE",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Caution"
    },
    {
      "name": "NBOMes",
      "status": "Caution"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Caution"
    },
    {
      "name": "Poppers",
      "status": "Unsafe"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Tramadol",
      "status": "Low Risk & Synergy"
    }
  ],
  "effects": null,
  "categorized_effects": {
    "Physical effects": [],
    "Mental effects": [],
    "Sensory effects": [],
    "Uncategorized effects": []
  }
}`,
  "tripsit-factsheets": `# AB-CHMINACA
*Source: TripSit Factsheets (tripsit.me)*

## Summary

A synthetic cannabinoid related to AB-FUBINACA. There have been reports of death in overdose, similar to AB-FUBINACA and it has a low threshold dose. Exercise caution.

## Classification
- **Categories:** research-chemical, habit-forming, tentative

## Dosage

### Oral
- **Common:** 100-250ug
- **Heavy:** 400ug+
- **Light:** 50-100ug
- **Strong:** 250-400ug

## Duration
- **Onset:** minutes
- **Duration:** hours
- **After Effects:** hours
`,
  "wikipedia": `# AB-CHMINACA
*Source: https://en.wikipedia.org/wiki/AB-CHMINACA*

AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor (Ki = 0.78 nM) and CB2 receptor (Ki = 0.45 nM) and fully substitutes for Î”9-THC in rat discrimination studies, while being 16x more potent. Continuing the trend seen in other cannabinoids of this generation, such as AB-FUBINACA and AB-PINACA, it contains a valine amino acid amide residue as part of its structure, where older cannabinoids contained a naphthyl or adamantane residue.

## Side effects

There have been a number of reported cases of seizures, deaths, and psychotic episodes in relation to this synthetic cannabinoid.

## Legal status

In 2015, AB-CHMINACA became a Schedule I controlled substance in the United States.
AB-CHMINACA is an Anlage II controlled substance in Germany as of May 2015.
As of October 2015 AB-CHMINACA is a controlled substance in China.
AB-CHMINACA is illegal in Switzerland as of December 2015.
AB-CHMINACA is an illegal substance in Russian Federation.
`,
};
